Genelux Corporation (GNLX) Monday announced that it has named Matthew Pulisic as its new Chief Financial Officer, effective January 30.
With 19 years of global biopharma experience, previously Pulisic served as Vice President of Finance at Arrowhead Pharmaceuticals, a publicly traded RNAi technology company.
GNLX is currently trading at $3.43 down 11.47 percent or $0.52 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.